Amneal Pharmaceuticals, Class Stock Market Value
| AMRX Stock | USD 7.83 0.09 1.14% |
| Symbol | Amneal |
Amneal Pharmaceuticals, Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amneal Pharmaceuticals,. If investors know Amneal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amneal Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.75) | Earnings Share (0.85) | Revenue Per Share 9.16 | Quarterly Revenue Growth 0.133 | Return On Assets 0.0594 |
The market value of Amneal Pharmaceuticals, is measured differently than its book value, which is the value of Amneal that is recorded on the company's balance sheet. Investors also form their own opinion of Amneal Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is Amneal Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amneal Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect Amneal Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amneal Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Amneal Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amneal Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Amneal Pharmaceuticals, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Amneal Pharmaceuticals,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Amneal Pharmaceuticals,.
| 11/14/2024 |
| 12/14/2024 |
If you would invest 0.00 in Amneal Pharmaceuticals, on November 14, 2024 and sell it all today you would earn a total of 0.00 from holding Amneal Pharmaceuticals, Class or generate 0.0% return on investment in Amneal Pharmaceuticals, over 30 days. Amneal Pharmaceuticals, is related to or competes with Alkermes Plc, Neurocrine Biosciences, Intracellular, Dynavax Technologies, Amphastar, Collegium Pharmaceutical, and Ironwood Pharmaceuticals. Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes... More
Amneal Pharmaceuticals, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Amneal Pharmaceuticals,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Amneal Pharmaceuticals, Class upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 11.27 | |||
| Value At Risk | (2.53) | |||
| Potential Upside | 3.28 |
Amneal Pharmaceuticals, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Amneal Pharmaceuticals,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Amneal Pharmaceuticals,'s standard deviation. In reality, there are many statistical measures that can use Amneal Pharmaceuticals, historical prices to predict the future Amneal Pharmaceuticals,'s volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (0.35) | |||
| Treynor Ratio | (0.12) |
Amneal Pharmaceuticals, Backtested Returns
Amneal Pharmaceuticals, secures Sharpe Ratio (or Efficiency) of -0.0816, which signifies that the company had a -0.0816% return per unit of risk over the last 3 months. Amneal Pharmaceuticals, Class exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Amneal Pharmaceuticals,'s Mean Deviation of 1.53, standard deviation of 1.96, and Risk Adjusted Performance of (0.03) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.95, which signifies possible diversification benefits within a given portfolio. Amneal Pharmaceuticals, returns are very sensitive to returns on the market. As the market goes up or down, Amneal Pharmaceuticals, is expected to follow. At this point, Amneal Pharmaceuticals, has a negative expected return of -0.16%. Please make sure to confirm Amneal Pharmaceuticals,'s standard deviation, potential upside, as well as the relationship between the Potential Upside and day median price , to decide if Amneal Pharmaceuticals, performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.17 |
Very weak predictability
Amneal Pharmaceuticals, Class has very weak predictability. Overlapping area represents the amount of predictability between Amneal Pharmaceuticals, time series from 14th of November 2024 to 29th of November 2024 and 29th of November 2024 to 14th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Amneal Pharmaceuticals, price movement. The serial correlation of 0.17 indicates that over 17.0% of current Amneal Pharmaceuticals, price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.17 | |
| Spearman Rank Test | 0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 0.09 |
Amneal Pharmaceuticals, lagged returns against current returns
Autocorrelation, which is Amneal Pharmaceuticals, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Amneal Pharmaceuticals,'s stock expected returns. We can calculate the autocorrelation of Amneal Pharmaceuticals, returns to help us make a trade decision. For example, suppose you find that Amneal Pharmaceuticals, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Amneal Pharmaceuticals, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Amneal Pharmaceuticals, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Amneal Pharmaceuticals, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Amneal Pharmaceuticals, stock over time.
Current vs Lagged Prices |
| Timeline |
Amneal Pharmaceuticals, Lagged Returns
When evaluating Amneal Pharmaceuticals,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Amneal Pharmaceuticals, stock have on its future price. Amneal Pharmaceuticals, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Amneal Pharmaceuticals, autocorrelation shows the relationship between Amneal Pharmaceuticals, stock current value and its past values and can show if there is a momentum factor associated with investing in Amneal Pharmaceuticals, Class.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Amneal Stock Analysis
When running Amneal Pharmaceuticals,'s price analysis, check to measure Amneal Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals, is operating at the current time. Most of Amneal Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.